Special Article: Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice

Practicing nephrologists are spending more time caring for end‐stage renal disease (ESRD) and chronic kidney disease (CKD) patients. Despite this focus, and considerable advances in the understanding of those aspects of care that impact on clinical outcomes, morbidity, mortality, and quality of life for these patients has not improved substantially over the past decade. One of the possible explanations for this lack of progress is the structure of current nephrology training programs, where ESRD and CKD patient care is not emphasized. To address this issue, we developed a short preceptorship for second‐year nephrology fellows, including didactic lectures and workshops. Of 67 participating fellows, 50% were from programs offering 3 or fewer months of exposure to outpatient hemodialysis, and 25% reported no exposure to peritoneal dialysis. Of more concern, 25% reported no “official rounds” with an attending nephrologist on dialysis patients. If nephrologists are to take their appropriate place as leaders of the care delivery team, nephrology fellowships must be restructured with appropriate emphasis placed on the comprehensive care of ESRD and CKD patients.

[1]  N. Powe,et al.  Screening for proteinuria in US adults: a cost-effectiveness analysis. , 2003, JAMA.

[2]  Nina Vasavada,et al.  Role of excess volume in the pathophysiology of hypertension in chronic kidney disease. , 2003, Kidney international.

[3]  C. Kjellstrand,et al.  Blood Access and Daily Hemodialysis: Clinical Experience and Review of the Literature , 2003, ASAIO journal.

[4]  S. Block,et al.  The need for end-of-life care training in nephrology: national survey results of nephrology fellows. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  J. Holley,et al.  Endocrinology and Dialysis: Issue and Therapies
Series Editor: Jean L. Holley: Pregnancy in Dialysis Patients: A Review of Outcomes, Complications, and Management , 2003, Seminars in dialysis.

[6]  C. Lenfant Shattuck lecture--clinical research to clinical practice--lost in translation? , 2003, The New England journal of medicine.

[7]  C. Saha,et al.  A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. , 2003, Kidney international.

[8]  A. P. Heidenheim,et al.  The London Daily/Nocturnal Hemodialysis Study--study design, morbidity, and mortality results. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Francesco Locatelli,et al.  Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2003, The New England journal of medicine.

[10]  N. Levinsky Controversies in nephrology: Con , 2003 .

[11]  A. Moss Too many patients who are too sick to benefit start chronic dialysis nephrologists need to learn to "just say no". , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  E. Friedman,et al.  Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2003, The New England journal of medicine.

[13]  M. Perazella Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension , 2003, Expert opinion on drug safety.

[14]  K. Chow,et al.  Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. , 2003, Annals of internal medicine.

[15]  Johanna T Dwyer,et al.  Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2002, The New England journal of medicine.

[16]  S. Efrati,et al.  ACE inhibitors and survival of hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  R. Agarwal Editorials: Assessment of Blood Pressure in Hemodialysis Patients , 2002, Seminars in dialysis.

[18]  G. Johnson,et al.  Diabetes education and care management significantly improve patient outcomes in the dialysis unit. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  N. Berman,et al.  An analysis of dialysis training in the United States and Canada. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  S. Linas Dialysis training in the United States. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Jackson T. Wright,et al.  A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  F. Bruns,et al.  Tidal Peritoneal Dialysis during Pregnancy Improves Clearance and Abdominal Symptoms , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[23]  Anabela S Rodrigues,et al.  Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis. , 2002, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[24]  R. Agarwal,et al.  Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  R. Agarwal,et al.  Prediction of hypertension in chronic hemodialysis patients. , 2001, Kidney international.

[26]  J. Díaz-Buxó,et al.  Potential Hazards of Polyglucose , 2001, ASAIO journal.

[27]  A. Collins,et al.  Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. , 2001, Journal of the American Society of Nephrology : JASN.

[28]  G. Becker,et al.  Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. , 2001, The New England journal of medicine.

[29]  D. Levine Shared decision-making in dialysis:The new RPA/ASN guideline on appropriate initiation and withdrawal of treatment , 2001 .

[30]  D. Levine Exploring Ethical, Moral, and Legal Issues Related to Kidney Diseases , 2001 .

[31]  W. Bennett Divided loyalties: relationships between nephrologists and industry. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  A. Moss Shared decision-making in dialysis: the new RPA/ASN guideline on appropriate initiation and withdrawal of treatment. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  B. Kasiske,et al.  Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.

[35]  W. White,et al.  Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  John H. Galla,et al.  Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis , 2000 .

[37]  Strategies and feasibility of hypertension control in a prevalent hemodialysis cohort. , 2000, Clinical nephrology.

[38]  C. L. Plante 1971 Medicare amendment: reflections on the passage of the end-stage renal disease Medicare program. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  G. Bakris,et al.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? , 2000, Archives of internal medicine.

[40]  G. Schreiner,et al.  How end-stage renal disease (ESRD)-medicare developed. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  W. van Biesen,et al.  An evaluation of an integrative care approach for end-stage renal disease patients. , 2000, Journal of the American Society of Nephrology : JASN.

[43]  G. Beck,et al.  Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. , 1999, Journal of the American Society of Nephrology : JASN.

[44]  D. Tarng,et al.  Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. , 1999, Kidney international.

[45]  I. Macdonald,et al.  Occult hypoglycemia caused by hemodialysis. , 1999, Clinical nephrology.

[46]  R. Agarwal Supervised atenolol therapy in the management of hemodialysis hypertension. , 1999, Kidney international.

[47]  R. Agarwal Role of home blood pressure monitoring in hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[49]  M C Smith,et al.  Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  R. Mehta,et al.  Assessment of dry weight in hemodialysis: an overview. , 1999, Journal of the American Society of Nephrology : JASN.

[51]  A. Babrow,et al.  Dialysis Patients' Preferences for Family-Based Advance Care Planning , 1999, Annals of Internal Medicine.

[52]  G. Kaysen,et al.  Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  B. Scribner,et al.  Blood pressure control in dialysis patients: importance of the lag phenomenon. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  Glassock Rj Nephrology workforce and time allocation: important issues for the future. , 1998 .

[55]  W. McClellan,et al.  Patterns of patient care reported by nephrologists: implications for nephrology training. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  C. Kjellstrand,et al.  Daily hemodialysis: dialysis for the next century. , 1998, Advances in renal replacement therapy.

[57]  D. Sutherland,et al.  Reversal of lesions of diabetic nephropathy after pancreas transplantation. , 1998, The New England journal of medicine.

[58]  B. Charra 'Dry weight' in dialysis: the history of a concept. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[59]  D. Sheikh-Hamad,et al.  Silent infection in clotted hemodialysis access grafts. , 1998, Journal of the American Society of Nephrology : JASN.

[60]  D. Churchill,et al.  Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. , 1998, Journal of the American Society of Nephrology : JASN.

[61]  T A Louis,et al.  A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[62]  R. Glassock Nephrology workforce and time allocation: important issues for the future. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[63]  W. White,et al.  Ambulatory blood pressure monitoring is a useful clinical tool in nephrology. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[64]  N. Madias,et al.  Nephrology core curriculum. The American Society of Nephrology and the American Society of Nephrology Training Program Directors Committee. , 1997, Journal of the American Society of Nephrology : JASN.

[65]  H. Ar The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997. , 1997 .

[66]  Y. Kawaguchi,et al.  Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. , 1997, Nephron.

[67]  A. Hull The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997. , 1997, Seminars in nephrology.

[68]  C. Kjellstrand,et al.  A prospective study of risk factors and decision making in discontinuation of dialysis. , 1996, Archives of internal medicine.

[69]  R. Townsend,et al.  Ambulatory blood pressure monitoring: coming of age in nephrology. , 1996, Journal of the American Society of Nephrology : JASN.

[70]  S. Hou Pregnancy in Women Treated with Peritoneal Dialysis: Viewpoint 1996 , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[71]  J. Díaz-Buxó Enhancement of peritoneal dialysis: the PD Plus concept. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[72]  B. Charra,et al.  Clinical assessment of dry weight. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  M. Rocco,et al.  Changes in Peritoneal Transport during the First Month of Peritoneal Dialysis , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[74]  D. Sica,et al.  Hormonal, Blood Pressure, and Peritoneal Transport Response to Short -Term Ace Inhibition , 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[75]  B. Charra Control of blood pressure in long slow hemodialysis. , 1994, Blood purification.

[76]  P. Grayburn,et al.  Effects of cooler temperature dialysate on hemodynamic stability in "problem" dialysis patients. , 1993, Kidney international.

[77]  R. Converse,et al.  Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.

[78]  R. Converse,et al.  Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. , 1992, The Journal of clinical investigation.

[79]  A. Nissenson Morbidity and Mortality of United States Dialysis Patients—–The Legacy of Inadequate Nephrologist Training? , 1992 .

[80]  B. Piraino,et al.  Effectiveness of renal fellowship training for subsequent clinical practice. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[81]  F. Portaluppi,et al.  Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. , 1991, American journal of hypertension.

[82]  L. Fine A proposal to improve the attractiveness of nephrology as a subspecialty choice for residents in internal medicine. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[83]  F. Coronel,et al.  Captopril, proteinuria and peritoneal protein leakage in diabetic patients. , 2008, Nephron.

[84]  E. Pohanka,et al.  PROGRESSION OF CHRONIC RENAL FAILURE , 1988, The Lancet.

[85]  G. D'Amico,et al.  Antihypertensive therapy in dialysed patients. , 1988, Contributions to nephrology.

[86]  R. Ward,et al.  Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes. , 1987, Kidney international.

[87]  C. Kjellstrand,et al.  Stopping long-term dialysis. An empirical study of withdrawal of life-supporting treatment. , 1986, The New England journal of medicine.

[88]  W. Henrich,et al.  The chronic efficacy and safety of high sodium dialysate: double-blind, crossover study. , 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[89]  A. J. Man in 't Veld,et al.  Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. , 1980, British medical journal.

[90]  M. Grajower,et al.  Hypoglycemia in chronic hemodialysis patients: association with propranolol use. , 1980, Nephron.

[91]  B. Sprangers,et al.  Core Curriculum in Nephrology , 2022 .